Patent classifications
D10B2509/00
BLANKET AND METHOD OF MANUFACTURE THEREOF
An example blanket includes: a yarn having a predefined length based on a target size of the blanket, wherein the yarn is interlaced to form the blanket, the yarn comprising: an outer layer comprising a first layer of fabric forming a tube, the outer layer having the predefined length and defining a fixed diameter of the tube and a fixed interior capacity of the tube based on the fixed diameter; and an inner layer comprising a second layer of fabric, having the predefined length and a width selected based on a target pressure to be applied over the target size of the blanket, wherein the inner layer is disposed in the tube to fill a portion of the fixed interior capacity of the tube.
PATIENT INTERFACE
A patient interface for delivery of a supply of pressurised air or breathable gas to an entrance of a patient's airways comprising: a cushion member that includes a retaining structure and a seal-forming structure permanently connected to the retaining structure; a frame member attachable to the retaining structure; and a positioning and stabilising structure attachable to the frame member.
KNITTED TISSUE SCAFFOLDS
Staple cartridge assemblies for use with surgical stapling instruments and methods for manufacturing the same are provided. Scaffolds for use with a surgical staple cartridge and methods for manufacturing the same are also provided.
YARN AND FABRIC WITH NANO-POWDER MIXTURE
A yarn made from a mixture of a grain and a first polymer by spinning is provides. The yarn includes a plurality of fibers. Each fiber has a surface layer and a core layer surrounded by the surface layer. The surface layer is made from the grain and the first polymer. The core layer is made from the first polymer. The grain includes a nano-powder mixture and a second polymer. A weight percentage of the nano-powder mixture in the grain is from 60% to 70%. The nano-powder mixture includes silicon dioxide, magnesium oxide and aluminum oxide. A weight ratio of silicon dioxide to magnesium oxide in the nano-powder mixture is from 2:1 to 1:2. A weight ratio of silicon dioxide to aluminum oxide in the nano-powder mixture is from 2:1 to 1:2.
TEXTILE SEAL WITH SILICONE LAYER
A patient interface comprises a cushion assembly including a textile membrane. The textile membrane includes an air impermeable silicone layer applied to a textile material. The textile material comprises 1) nylon and/or polyester, and 2) elastane. A yarn count of the nylon and/or polyester is in a range of 20-80 denier, and the textile material has stretchability in both a direction of the wales and a direction of the course.
Medicated thread manufacturing system and medicated thread manufacturing method
A medicated thread manufacturing system and associated method includes first and second slideways, a thread clamping apparatus and a medicine spraying apparatus slidably arranged on the first slideway, and a thread winding apparatus slidably arranged on the second slideway. The clamping apparatus clamps two ends of a to-be-processed medicated thread, straightens the thread and twists the thread in the straightened state into a single-strand rope state. The spraying apparatus sprays a medicine towards a surface layer of the thread in the straightened state. The winding apparatus abuts a center position of the thread in the single-strand rope state, pulls and folds the thread, and rotates the thread such that the thread winds and extends from middle to two ends to be twisted in a double-strand rope state. A control apparatus is in signal connection and/or electrical connection to the clamping apparatus, the spraying apparatus and the winding apparatus.
METHOD OF FORMING BIODEGRAD ABFE NONWOVEN FABRIC, NONWOVEN FABRIC OBTAINED BY THIS METHOD, AND SYSTEM OF DEVICES FOR CARRYING OUT THIS METHOD
The invention relates to a method of forming a biodegradable nonwoven fabric, the nonwoven fabric obtained by this method, and a system of devices for carrying out this method, to be used for the manufacture of cellulosic articles for clean-up work and sanitary products, and medical uses.
COLLAGENOUS TISSUE REPAIR DEVICE
Methods and devices for tissue remodeling and repair of collagenous tissues, including tendons, ligaments, and bone, as well as scalable connective tissue manufacturing, are provided. Collagen fibers are assembled by extensional strain-induced flow crystallization of collagen monomers. Extensional strain also drives the fusion of already formed short collagen fibrils to produce long-range, continuous fibers. Wearable devices for controlled tissue remodeling and wound healing deliver a tissue remodeling solution to a tissue repair site. The remodeling solution, together with appropriate application of strain to the tissue remodeling site, accelerate healing, prevent injury, and reduce scar formation.
TAMPON WITH CONSOLIDATED FIBROUS ASSEMBLY AND METHOD OF MAKING
The present disclosure describes a tampon article, a composite fibrous web, and a method of making same. Such an article includes an outer carrier component including an inner surface that defines an internal void. Including an absorbent component elongate along an axis and is disposed in the internal void. The absorbent component includes an outer surface that extends about the axis and faces the inner surface. The absorbent component further includes a composite fibrous web of staple cellulosic fibers and a meltspun web of filaments entangled with the web of staple cellulosic fibers. The composite fibrous web can be in a compressed configuration in the internal void such that at least portion of the outer surface of the absorbent component is defined by the meltspun web of filaments. The tampon can include a withdrawal cord coupled to the absorbent component.
ENCAPSULATION OF BIOACTIVE INGREDIENTS BY MULTIPLEX EMULSION
Described herein are various three-dimensional fiber structures that have multiple polymer fiber layers with an active therapeutic agent entrained in the polymer fiber layers. Further described are methods for forming the three-dimensional fiber structures where the method includes centrifugal spinning of an emulsion containing polymer(s) and the active therapeutic agent(s).